1. Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non‐small‐cell lung cancer. (28th November 2019) Authors: Selcukbiricik, Fatih; Ozdogan, Elif; Dagel, Tuncay; Tanju, Serhan; Erus, Suat; Ertuglu, Lale A.; Kapdağlı, Murat; Tural, Deniz; Bilici, Ahmet; Dilege, Sukru; Mandel, Nil M.; Kanbay, Mehmet Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 45:Number 2(2020) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗